Ordeniza, Lexie Zane Y.
HRN: 21-35-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
MUPIROCIN 2%, 15G (TUBE)
10/21/2022
10/28/2022
TOPICAL
Apply On Affected Area
Q8
IV Puncture Site Wounds
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes